>99% Purity
HPLC Verified
QC Tested
Every Batch
Fast Ship
24-48 Hours
Tirzepatide
Purity: >99%
Select vial size:
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide has been the subject of extensive preclinical and clinical research for its role in metabolic studies. For laboratory research use only.
In Stock — Ships within 24-48 hours
USPS Priority ($15) or Express ($25) shipping
For laboratory and research use only
- Name: Tirzepatide
- Dosage / Size: 20mg
- Purity: >99% (HPLC Verified)
- Category: GLP-1 Agonists
- Form: Lyophilized powder
- Intended Use: Laboratory & scientific research only
Research Studies & Clinical Trials
SURPASS Program
The SURPASS clinical trial program is one of the largest global research programs evaluating tirzepatide. Key trials include:
SURPASS-1 (NCT03954834) A Phase 3, randomized, double-blind, placebo-controlled study evaluating tirzepatide monotherapy. Results published in The New England Journal of Medicine (2021) demonstrated significant effects on glycemic parameters.
SURPASS-2 (NCT03987919) A head-to-head comparison study against semaglutide 1mg. Published in NEJM (2021), demonstrating superior A1C reduction.
SURPASS-3 (NCT03882970) Compared tirzepatide with insulin degludec in research subjects. Published in The Lancet (2021).
SURPASS-4 (NCT03730662) A cardiovascular outcomes-focused study comparing tirzepatide with insulin glargine. Published in The Lancet (2021).
SURMOUNT Program
SURMOUNT-1 (NCT04184622) A Phase 3 study evaluating tirzepatide in metabolic research. Results showed dose-dependent effects at 5mg, 10mg, and 15mg doses. Published in NEJM (2022).
SURMOUNT-2 (NCT04657003) Evaluated tirzepatide in subjects with type 2 diabetes. Published in The Lancet (2023).
Mechanism of Action Research
Preclinical studies demonstrate tirzepatide activates both GIP and GLP-1 receptors with a bias toward GIP receptor agonism. Research published in Cell Metabolism (2020) elucidates the dual incretin mechanism.
Customer Reviews
Best tirzepatide available for research. Arrived cold-packed and the CoA was impressive.
Excellent sourcing and fast delivery. Our incretin research is running beautifully.
Our metabolic research team was blown away by the consistency between batches.
Incredible purity for a dual agonist. Our GIP/GLP-1 receptor binding studies produce reproducible results every run.
High quality peptide. Dissolves well. Slightly pricier than competitors but purity justifies it.
Third order. Consistent quality, fast ship time, packaging was excellent. Highly recommend.
Our SURPASS replication models are running flawlessly with this batch. Top quality.
Seventh order. Every single batch identical in quality. Truly remarkable consistency.
Our lab director specifically requested we stay with Bausch. The quality speaks for itself.
We've tried 4 suppliers. Bausch is the only one that consistently passes our internal QC.
Exceptional batch-to-batch consistency. Our metabolic disease models rely on this.
Our dual-receptor assays have never been more consistent. This is research-grade in every sense.
Great quality. CoA is thorough. Will definitely continue ordering for our research program.
Very impressed. Mass spec confirmed the purity claims perfectly.
Verified purity is everything in dual-agonist research. Bausch delivers every time.
Outstanding quality. We have strict requirements and this peptide passed every test.
Reliable, pure, and fast shipping. Exactly what a research lab needs.
Research-grade as advertised. Our GLP-1 binding assays confirmed >99% purity. Will reorder.
Great product overall. CoA was clean. Would love slightly faster communication but quality is perfect.
Fast shipping, pristine packaging, and flawless purity. 5 stars without hesitation.
Customers Also Viewed
View all
Research Use Only
All products sold by Bausch Pharma are intended strictly for laboratory and scientific research purposes. These products are not intended for any other use. By browsing and purchasing from this website, you confirm you are at least 21 years of age and a qualified researcher.